General Information of the Compound
Compound ID
CP0382753
Compound Name
4-[(1R,3R)-3-[(5-chloro-2-methoxyanilino)methyl]-2,2-dimethylcyclopropyl]benzenesulfonamide
    Show/Hide
Synonyms
BNC375
    Show/Hide
Structure
Formula
C19H23ClN2O3S
Molecular Weight
394.924
Canonical SMILES
COc1ccc(Cl)cc1NC[C@@H]1[C@@H](c2ccc(cc2)S(N)(=O)=O)C1(C)C
    Show/Hide
InChI
InChI=1S/C19H23ClN2O3S/c1-19(2)15(11-22-16-10-13(20)6-9-17(16)25-3)18(19)12-4-7-14(8-5-12)26(21,23)24/h4-10,15,18,22H,11H2,1-3H3,(H2,21,23,24)/t15-,18-/m1/s1
    Show/Hide
InChIKey
LWWDCTBUJUEFDE-CRAIPNDOSA-N
Physicochemical Property
logP
3.8477
Rotatable Bonds
6
Heavy Atom Count
26
Polar Areas
81.42
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 118160666
ChEMBL ID
CHEMBL4456125
Clinical Information about the Compound
Drug 1 ( BNC375 )
Drug Name BNC375
Company Merck Kenilworth, NJ Bionomics Thebarton, Australia
Indication
Cognitive impairment
Phase 1
Target(s)
Neuronal acetylcholine receptor alpha-7 (CHRNA7)
Modulator